Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of NRTI resistance mutations on virological effectiveness of antiretroviral regimens containing elvitegravir: a multi-cohort study.
Modica S, Redi D, Gagliardini R, Giombini E, Bezenchek A, Di Carlo D, Maggiolo F, Lombardi F, Borghetti A, Farinacci D, Callegaro A, Gismondo MR, Colafigli M, Sterrantino G, Costantini A, Ferrara SM, Rusconi S, Zazzi M, Rossetti B, De Luca A, Gianotti N. Modica S, et al. Among authors: bezenchek a. J Antimicrob Chemother. 2020 Jan 1;75(1):194-199. doi: 10.1093/jac/dkz424. J Antimicrob Chemother. 2020. PMID: 31605107
Letter to the editor: switching treatment to lamivudine plus boosted atazanavir or darunavir in virologically suppressed HIV-infected patients - evidence from a large observational cohort.
Bavaro DF, Di Carlo D, Zuccalà P, Bai F, Incardona F, Battisti A, Giachè S, Salomoni E, Gagliardini R, Di Giambenedetto S, Pecorari M, Zazzi M, De Luca A, Bezenchek A, Lo Caputo S. Bavaro DF, et al. Among authors: bezenchek a. Infect Dis (Lond). 2019 Mar;51(3):234-239. doi: 10.1080/23744235.2018.1544423. Epub 2019 Jan 21. Infect Dis (Lond). 2019. PMID: 30663927 No abstract available.
Evaluation of HIV-1 integrase resistance emergence and evolution in patients treated with integrase inhibitors.
Scutari R, Alteri C, Vicenti I, Di Carlo D, Zuccaro V, Incardona F, Borghi V, Bezenchek A, Andreoni M, Antinori A, Perno CF, Cascio A, De Luca A, Zazzi M, Santoro MM; ARCA (Antiviral Response Cohort Analysis) Study Group. Scutari R, et al. Among authors: bezenchek a. J Glob Antimicrob Resist. 2020 Mar;20:163-169. doi: 10.1016/j.jgar.2019.07.015. Epub 2019 Jul 19. J Glob Antimicrob Resist. 2020. PMID: 31330378 Free article.
Prevalence and factors associated with HIV-1 multi-drug resistance over the past two decades in the Italian ARCA database.
Lombardi F, Giacomelli A, Armenia D, Lai A, Dusina A, Bezenchek A, Timelli L, Saladini F, Vichi F, Corsi P, Colao G, Bruzzone B, Gagliardini R, Callegaro A, Castagna A, Santoro MM; ARCA Study Group. Lombardi F, et al. Among authors: bezenchek a. Int J Antimicrob Agents. 2021 Feb;57(2):106252. doi: 10.1016/j.ijantimicag.2020.106252. Epub 2020 Nov 28. Int J Antimicrob Agents. 2021. PMID: 33259914 Free article.
Predictors of Virological Failure Among People Living with HIV Switching from an Effective First-Line Antiretroviral Regimen.
Magnasco L, Pincino R, Pasculli G, Bouba Y, Saladini F, Bavaro DF, De Vito A, Lattanzio R, Corsini R, Zazzi M, Incardona F, Rossetti B, Bezenchek A, Borghi V, Di Biagio A. Magnasco L, et al. Among authors: bezenchek a. AIDS Res Hum Retroviruses. 2022 Jun;38(6):463-471. doi: 10.1089/AID.2021.0016. Epub 2022 Feb 10. AIDS Res Hum Retroviruses. 2022. PMID: 34969260
Early versus delayed antiretroviral therapy based on genotypic resistance test: Results from a large retrospective cohort study.
Bavaro DF, De Vito A, Pasculli G, Bouba Y, Magnasco L, Pincino R, Saladini F, Lattanzio R, Corsini R, Arima S, Zazzi M, Incardona F, Rossetti B, Bezenchek A, Vanni B, Di Biagio A. Bavaro DF, et al. Among authors: bezenchek a. J Med Virol. 2022 Aug;94(8):3890-3899. doi: 10.1002/jmv.27754. Epub 2022 Apr 9. J Med Virol. 2022. PMID: 35355293 Free PMC article.
Impact of pre-existent drug resistance on virological efficacy of single-tablet regimens in people living with HIV.
Stella G, Volpicelli L, Carlo DD, Vicenti I, Celani L, Maggiolo F, Callegaro AP, Gennari W, Francisci D, Lombardi F, Piermatteo L, Bezenchek A, Micheli V, Rossetti B, Santoro MM; ARCA Study Group. Stella G, et al. Among authors: bezenchek a. Int J Antimicrob Agents. 2022 Sep;60(3):106636. doi: 10.1016/j.ijantimicag.2022.106636. Epub 2022 Jul 9. Int J Antimicrob Agents. 2022. PMID: 35820534
Factors Associated with Low-Level Viremia in People Living with HIV in the Italian Antiviral Response Cohort Analysis Cohort: A Case-Control Study.
Lombardi F, Bruzzesi E, Bouba YR, Di Carlo D, Costabile V, Ranzenigo M, Maggiolo F, Castagna A, Callegaro AP, Zoncada A, Paolucci S, Micheli V, Renica S, Bezencheck A, Rossetti B, Santoro MM. Lombardi F, et al. AIDS Res Hum Retroviruses. 2024 Feb;40(2):80-89. doi: 10.1089/AID.2023.0015. Epub 2023 Jul 14. AIDS Res Hum Retroviruses. 2024. PMID: 37345697
Trend over time of HIV-1 drug resistance to nonnucleoside reverse transcriptase inhibitors (NNRTIs) and their drivers: A cohort study from Antiviral Response Cohort Analysis (ARCA).
Rancan I, Cassol C, Graziani L, Tilli M, Malcontenti C, Russo C, Bottanelli M, Bracchitta F, Papaioannu R, Labate L, Mora S, Bezenchek A, Shallvari A, Di Biagio A, Rossetti B. Rancan I, et al. Among authors: bezenchek a. HIV Med. 2023 Nov;24(11):1150-1157. doi: 10.1111/hiv.13525. Epub 2023 Jul 13. HIV Med. 2023. PMID: 37439411
15 results